Abstract:Objectives: COPD is characterized by progressive airway obstruction. Recent studies showed that besides nitric oxide (NO) and carbon monoxide (CO), endogenous hydrogen sulfide (H2S) might be the third signaling gasotransmitter. To clarify the role of endogenous H,S in the pathogenesis of COPD, we investigated the relation of serum H2S level to severity of COPD as defined by lung function and airway inflammation.Methods: Levels Of Serum H2S and NO, lung function, and cell differential counts in induced sputum were studied in 27 patients with acute exacerbation of COPD (AECOPD), 37 patients with stable COPD, and 13 healthy subjects. Patients with AECOPD had arterial blood gas levels measured and underwent Doppler echocardiography. In addition, in order to clarify the effects of age and smoking status on serum H2S level, we recruited three groups who were age matched to the study group but had no airflow hinitation (59 subjects).Results: Serum H2S level (34.0 +/- 0.9 to 36.4 +/- 1.1 mu mol/L [+/- SEM]) did not differ among healthy control subjects with different ages (56.6 to 75.0 years, respectively). Serum H2S level was significantly higher in patients with stable COPD than in patients with AECOPD and age-matched control subjects (p < 0.01) and correlated positively with NO level in all healthy control subjects and all patients with COPD (r = 0.352, p = 0.000). Serum H2S level was significantly lower in smokers than nonsmokers, both with AECOPD (p < 0.05) and healthy control subjects (p < 0.01). It was significantly lower in smokers with AECOPD than healthy smokers and smokers with stable COPD (p < 0.01). Serum H2S level differed and was decreased (p < 0.05) among stable COPD patients by stage of airway obstruction (p < 0.05), and it was lower in patients with stage III than stage I obstruction (p < 0.05). Serum H2S level in all patients with COPD and healthy control subjects con-elated positively with the percentage of predicted FEV1 value (r = 0.300, p = 0.009). It was lower in patients with AECOPD and systolic pulmonary artery pressure (PASP) >= 35 mm Hg than those with PASP within the normal range (< 35 mm 14g) [p < 0.05] and was negatively correlated with PASP (r = - 0.561, p = 0.011). Serum H2S level was negatively correlated with proportion of neutrophils in sputuni (r = -0.422, p = 0.001) and positively correlated with proportion of lymphocytes (r = 0.286, p = 0.028) and niacrophages (r = 0.334, p = 0.01) in all patients with COPD.Conclusions: Endogenous H2S is involved in the pathogenesis of airway obstruction in COPD, and its alteration in level may be connected with disease activity and severity.

Changes of Hydrogen Sulfide in Patients with Chronic Pulmonary Heart Disease and Connection with Cardiac Function

[Changes of the New Gaseous Transmitter H2S in Patients with Coronary Heart Disease].

Changes Hydrogen Sulfide in Plasma of Children with Congenital Heart Disease

[Plasma Level of Endogenous Hydrogen Sulfide in Patients with Acute Asthma].

Imbalance of Endogenous Hydrogen Sulfide and Homocysteine in Chronic Obstructive Pulmonary Disease Combined with Cardiovascular Disease

Relationship Between Endogenous Hydrogen Sulfide and Pulmonary Vascular Indexes on High-Resolution Computed Tomography in Patients with Chronic Obstructive Pulmonary Disease

Endogenous Hydrogen Sulfide in Patients with COPD

Low Plasma Hydrogen Sulfide is Associated with Impaired Renal Function and Cardiac Dysfunction

Endogenous Hydrogen Sulfide is Impaired in Patients with Chronic Obstructive Pulmonary Disease

Exhaled Hydrogen Sulfide in Patients with Chronic Obstructive Pulmonary Disease and Its Correlation with Exhaled Nitric Oxide

Exhaled Hydrogen Sulfide in Patients with Copd

Serum Hydrogen Sulfide Reduces in Idiopathic Pulmonary Fibrosis Patients

Cardioprotection of H2S by downregulating iNOS and upregulating HO-1 expression in mice with CVB3-induced myocarditis

Correlation Between Levels of Exhaled Hydrogen Sulfide and Airway Inflammatory Phenotype in Patients with Chronic Persistent Asthma.

Changes of Endogenous Nitric Oxide and Hydrogen Sulfide in Plasma of Children with Congenital Heart Disease Complicated with Pulmonary Hypertension

[Plasma Hydrogen Sulfide and Homocysteine Levels in Hypertensive Patients with Different Blood Pressure Levels and Complications].

Changes of Endogenous Hydrogen Sulfide in Plasma of Newborn Infant with Pulmonary Hypertension

Changes of A New Gaseous Signal Molecule-Hydrogen Sulfide in Children with Hyperlipidemia

Exhaled Hydrogen Sulfide Predicts Airway Inflammation Phenotype in COPD.

Metabolic Changes of H2S in Smokers and Patients of COPD Which Might Involve in Inflammation, Oxidative Stress and Steroid Sensitivity

[The Dynamic Changes in Endogenous Hydrogen Sulfide Pathway at the Early Stage of Pulmonary Hypertension Induced by High Pulmonary Flow in Rats].